26 related articles for article (PubMed ID: 38490063)
1. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
[TBL] [Abstract][Full Text] [Related]
3. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library.
Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S
Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933
[TBL] [Abstract][Full Text] [Related]
4. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
[TBL] [Abstract][Full Text] [Related]
5. Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors.
Rullo M; La Spada G; Miniero DV; Gottinger A; Catto M; Delre P; Mastromarino M; Latronico T; Marchese S; Mangiatordi GF; Binda C; Linusson A; Liuzzi GM; Pisani L
Eur J Med Chem; 2023 Jul; 255():115352. PubMed ID: 37178666
[TBL] [Abstract][Full Text] [Related]
6. Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity.
Al-Saad OM; Gabr M; Darwish SS; Rullo M; Pisani L; Miniero DV; Liuzzi GM; Kany AM; Hirsch AKH; Abadi AH; Engel M; Catto M; Abdel-Halim M
Eur J Med Chem; 2024 Apr; 269():116266. PubMed ID: 38490063
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies.
Naoi M; Maruyama W; Shamoto-Nagai M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232361
[TBL] [Abstract][Full Text] [Related]
8. Lights and shadows on monoamine oxidase inhibition in neuroprotective pharmacological therapies.
Binda C; Milczek EM; Bonivento D; Wang J; Mattevi A; Edmondson DE
Curr Top Med Chem; 2011 Nov; 11(22):2788-96. PubMed ID: 22039878
[TBL] [Abstract][Full Text] [Related]
9. Selective MAO-B inhibitors: a lesson from natural products.
Carradori S; D'Ascenzio M; Chimenti P; Secci D; Bolasco A
Mol Divers; 2014 Feb; 18(1):219-43. PubMed ID: 24218136
[TBL] [Abstract][Full Text] [Related]
10. Drugs related to monoamine oxidase activity.
Fišar Z
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():112-24. PubMed ID: 26944656
[TBL] [Abstract][Full Text] [Related]
11. Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival.
Naoi M; Maruyama W; Inaba-Hasegawa K
Curr Top Med Chem; 2012; 12(20):2177-88. PubMed ID: 23231395
[TBL] [Abstract][Full Text] [Related]
12. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
